Hôpitaux de Paris, Hôpital Européen Georges Pompidou, France bINSERM U970, France.
J Hypertens. 2011 Jun;29(6):1034-42. doi: 10.1097/HJH.0b013e328346a583.
Arterial stiffness is an independent predictor of cardiovascular events and mortality in hypertensive patients. The influence of different antihypertensive drug classes on improving arterial stiffness beyond blood pressure reduction is not widely available. We aimed to determine whether the artery stiffness can be improved because of antihypertensive treatments independently of blood pressure lowering.
We conducted a meta-analysis of individual data from 15 randomized, controlled, double-blind, parallel group trials performed in our laboratory between 1987 and 1994. The primary endpoint was the changes of carotid-femoral pulse wave velocity (PWV) after treatment in 294 patients with mild-to-moderate essential hypertension untreated. Treatments tested were placebo (n = 88), angiotensin-converting enzyme inhibitors (ACEIs) (n = 75), calcium antagonists (n = 75), beta-blocker (n = 30), and diuretic (n = 26).
In the short-term and long-term trials, PWV decreased significantly by -0.75 and -1.3 m/s in the active treatment group compared with by +0.17 and -0.44 m/s in the placebo group, respectively. Active treatment was independently related to the changes in PWV and explained 5 and 4% of the variance in the short-term and long-term trials, respectively. In the short-term trials, ACEIs were more effective than calcium antagonists and placebo on improving arterial stiffness. In the long-term trials, ACEI, calcium antagonists, beta-blocker, and diuretic reduced significantly PWV compared to placebo.
Our study shows that antihypertensive treatments improve the arterial stiffness beyond their effect on blood pressure.
动脉僵硬度是高血压患者心血管事件和死亡率的独立预测因子。不同降压药物类别对改善动脉僵硬度的影响超出了降压作用,目前尚未广泛研究。我们旨在确定降压治疗是否可以改善动脉僵硬度,而不仅仅是通过降低血压。
我们对 1987 年至 1994 年在我们实验室进行的 15 项随机、对照、双盲、平行组试验的个体数据进行了荟萃分析。主要终点是未经治疗的 294 例轻度至中度原发性高血压患者治疗后颈股脉搏波速度(PWV)的变化。试验中测试的治疗方法为安慰剂(n=88)、血管紧张素转换酶抑制剂(ACEI)(n=75)、钙拮抗剂(n=75)、β受体阻滞剂(n=30)和利尿剂(n=26)。
在短期和长期试验中,与安慰剂组相比,PWV 在活性治疗组中分别显著下降-0.75 和-1.3 m/s,而在安慰剂组中分别增加+0.17 和-0.44 m/s。活性治疗与 PWV 的变化独立相关,分别解释了短期和长期试验中 5%和 4%的方差。在短期试验中,ACEI 在改善动脉僵硬度方面比钙拮抗剂和安慰剂更有效。在长期试验中,ACEI、钙拮抗剂、β受体阻滞剂和利尿剂与安慰剂相比,PWV 显著降低。
我们的研究表明,降压治疗可改善动脉僵硬度,而不仅仅是通过降低血压。